Synlogic, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States.
Synlogic stock last closed at $1.05, down 5.41% from the previous day, and has decreased 29.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.13 percentage points. Synlogic stock is currently +16.93% from its 52-week low of $0.90, and -46.43% from its 52-week high of $1.96.
As of Dec 15, 2025, there are 11.7M shares of SYBX outstanding. The market capitalization of SYBX is $12.28M. In the last 24 hours, 30,400 SYBX shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy SYBX shares.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal info so you can buy SYBX today.
Now that you have created your account on the best stock market app for beginners, you need to deposit funds:
Watch the video below to see the process of depositing money into your new brokerage account.
After you have decided on the best place to buy Synlogic stock, it's important to analyze their stock before you buy, so you can understand the risk as well as the upside.
WallStreetZen was built to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on SYBX's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SYBX's fair value.
Using relative valuations metrics:
You can access more valuation analysis on SYBX's stock here.
You can dive deeper into what analysts are projecting on the Synlogic stock forecast page.
Last year, SYBX revenue was $0.00. During the last five year, SYBX's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 43.87%.
Dig into SYBX's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at SYBX have sold more shares than they have bought.
Mary Beth Dooley, Principal Executive Officer and Principal Financial Officer of SYBX, was the latest SYBX insider to sell. They sold $284.17 worth of SYBX stock on Oct 29, 2025.
Get more info about who owns SYBX shares here.
No, Synlogic doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main options:
Hit the Open Trade button and your broker will execute the order.
If you want more assistance buying stocks on eToro, click the how to video below:
Now that you own some SYBX stock, you'll want to keep up with your new shares.
Create a watchlist to get the latest updates about your SYBX stock.
To reiterate, here are the 6 steps for buying Synlogic stock:
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your new investment in Synlogic, click the button below.